BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Leukemia
,
Heart
,
Metabolism of nitric oxide
,
Clofibrate
,
rs6983267
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fancd2 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Hematopoietic stem cells (HSC) and erythroblasts from Fancd2 knockout mice treated with oxymetholone
Chronic myeloid leukemias with BCR-ABL fusions before and after imatinib mesylate treatment
Embryonic kidney HEK293T cells with CRISPR-mediated RBBP8 knockout
Cervical cancer primary biopsies prospectively linked to cisplatin/radiation therapy response
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of FANCD2 and related proteins may predict malignant transformation in oral epithelial dysplasi…
Sterigmatocystin, 5-Methoxysterigmatocistin, and Their Combinations Are Cytotoxic and Genotoxic to A…
FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 …
Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in h…
Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung …
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR)…
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ